Inaccurate data stalls pediatric equity initiatives

Leaders at three Michigan hospitals aiming to address equity issues for pediatric patients wanted to start with inspecting data key to identifying potential inequities.

Amylyx axes ALS drug from market after Phase III failure – Pharmaceutical Technology

Share this article Amylyx’ ALS candidate Relyvrio has been taken off the market following a Phase III trial that missed its endpoints. Credit: MacroEcon via

April 5, 2024

Teen Smoking, Other Tobacco Use Dropped to Lowest Level in 25 Years, CDC Reports

Teen smoking hit an all-time low in the U.S. this year, part of a big drop in the use of tobacco among youths overall, the

October 19, 2024

Effective Treatments Identified for Pediatric Complication of COVID

PHOENIX — First-line treatment with methylprednisolone and second-line treatment with tocilizumab (Actemra) shortened hospital stays for children with pediatric multisystem inflammatory syndrome temporally associated with

January 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.